"Pioneers for sustainable health: Das Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM ist eines von über 70 Instituten der Fraunhofer-Gesellschaft, der größten Organisation für anwendungsorientierte Forschung in Europa. Ziele der Auftragsforschung am Fraunhofer ITEM sind es, den Menschen in unserer industrialisierten Welt vor gesundheitlicher Gefährdung zu schützen und an der Entwicklung neuer therapeutischer Ansätze mitzuwirken. Mit Schwerpunkt auf der Atemwegsforschung umfasst das FuE-Portfolio drei Geschäftsfelder: die Arzneimittelentwicklung, die Chemikalienbewertung sowie die translationale Medizintechnik."

During the past decade, Fraunhofer Institute for Toxicology and Experimental Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fraunhofer Institute for Toxicology and Experimental Medicine" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Federal Institute for Occupational Safety and Health (BAuA)/Germany)" with 1 trials as a collaborator and "Hannover Medical School" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fraunhofer Institute for Toxicology and Experimental Medicine" are "Healthy" (3 trials), "Asthma" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Allergic Rhinitis" (1 trials) and "Allergy to House Dust Mite" (1 trials). Many other conditions were trialed in "Fraunhofer Institute for Toxicology and Experimental Medicine" in a lesser frequency.

Most popular intervention types in "Fraunhofer Institute for Toxicology and Experimental Medicine" are "Drug" (7 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "SB010" (2 trials), "Allergen-free air" (1 trials), "Bronchoscopy" (1 trials) and "Clean air" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fraunhofer Institute for Toxicology and Experimental Medicine" are 8 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Fraunhofer Institute for Toxicology and Experimental Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Fraunhofer Institute for Toxicology and Experimental Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fraunhofer Institute for Toxicology and Experimental Medicine, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".